![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of p... Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Show more
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on...
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.53 | 3.125 | 16.96 | 17.99 | 16.74 | 904527 | 17.42559955 | CS |
4 | 1.97 | 12.6932989691 | 15.52 | 17.99 | 14.97 | 765009 | 16.5920032 | CS |
12 | 2.68 | 18.0958811614 | 14.81 | 17.99 | 14.47 | 1062100 | 15.95288529 | CS |
26 | 3.13 | 21.7966573816 | 14.36 | 17.99 | 13.1161 | 1202559 | 15.53373356 | CS |
52 | 3.48 | 24.8394004283 | 14.01 | 17.99 | 11.55 | 1271123 | 14.64769003 | CS |
156 | 11.6 | 196.943972835 | 5.89 | 22.11 | 4.81 | 1606738 | 13.02049992 | CS |
260 | 12.54 | 253.333333333 | 4.95 | 22.11 | 2.55 | 1705166 | 9.23755819 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions